Inspra Helps, Natrecor Useless for Heart Patients
By wchung | 27 Mar, 2026
There’s good news for millions of people with mild or moderate heart failure. Studies show that the Pfizer drug Inspra and an implanted device from Medtronic can boost survival and cut down on trips to the hospital.
However, another drug that has been used for nearly a decade, Johnson & Johnson’s Natrecor (NAY’-treh-kor), did little to help people with severe heart failure in a study aimed at resolving safety concerns. Doctors say the drug seems safe but does not markedly help shortness of breath or save lives.
The studies were presented Sunday at an American Heart Association conference in Chicago.
MARILYNN MARCHIONE, AP Medical Writer CHICAGO
Articles
- Tiger Woods Arrested for DUI After Florida Rollover
- BTS Tops UK Charts with Comeback Album
- Let's Be Good Again So We Can Be Great Again
- Iran-Linked Hackers Access FBI Director's Personal Email, Publish Online
- US Can Confirm Only a Third of Iran's Missile Arsenal Destroyed,
- Chinese Ships Balk at Hormuz Despite Safe Passage Assurances from Iran
- SpaceX Listing Stirs Social Media Frenzy, Ticker Bets
- Sony to Hike PlayStation 5 Prices Again on Surge in Memory Chip Costs
- Huawei's AI Chip Earns Credibility with ByteDance, Alibaba Orders
- SoftBank Secures $40 Billion Loan for More OpenAI Investments